Federal contractor · LLANERA

CYCLOPE BIO SL

CYCLOPE BIO SL received $80K in federal contract obligations in FY2026, on 2 awards (−43% vs FY2025). Since FY2024: $319K. Its largest customer was National Institutes of Health ($80K).

Obligations · FY2026
$80K
New awards
2
Sole-source
100%
Single offer
0.0%
UEI
K929DS87AWG9
Other than small business

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 99KFY2024
  2. 140KFY2025
  3. 80KFY2026

Top buying agencies

Obligations in FY2026.

  1. 2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Other equipment & supplies$80K100%

Where the work was performed

  1. Abroad$80K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $80K
  • Sole-source awards100%
    US 30% · $80K
  • Single-offer competitions0.0%
    US 8.8% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

  1. Department of Health and Human Services · 1 awards

Largest awards

  1. National Institutes of Health· Other equipment & supplies· Sep 10, 2025 – May 21, 2026· 75N94025P00590
  2. National Institutes of Health· Other equipment & supplies· Jun 22, 2026 – Jun 22, 2026· 75N98026P00833

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. WARNER GRAHAM LLLP$133.6K−61% in FY2026
    COCKEYSVILLE, MD · 42% of this company's obligations are in markets they both serveNational Institutes of Health · Basic chemical manufacturing
  2. CRYO-EXPRESS, LLC$1.3M−15% in FY2026
    GAITHERSBURG, MD · 2 entities · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Basic chemical manufacturing
  3. PINE PHARMACEUTICALS LLC$1.3M+40% in FY2026
    TONAWANDA, NY · 39% of this company's obligations are in markets they both serveNational Institutes of Health · Basic chemical manufacturing

Showing the top 3 of 16 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.